Skip navigation

DAY ONE TUESDAY, JANUARY 31, 2017

7:30

Conference Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Evaluate Legislative and Enforcement Trends Involving FCPA and Investigation Programs

8:45

LUMINARY ADDRESS Why Everyone in Your Organization Needs to Care about
Anti-Corruption (And Do They Really?)

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
Former FCPA Violator and FBI/UK Cooperator

Gary Giampetruzzi
Partner, Litigation Department
Paul Hastings

9:45

FCPA Enforcement Trends and Updates

MODERATOR:

John E. Kelly
Member
Bass, Berry & Sims

PANELISTS:

Glenn Pomerantz
Partner
BDO

Christian Perez Font
Chief Compliance Officer
OPKO Health

Maria Villanueva Sessions
Director of Compliance
Zimmer Biomet

10:45

Networking and Refreshment Break

11:15

FORMER PROSECUTOR VIEWPOINTS Life Sciences Enforcement Updates, Trends and Predictions

MODERATOR:

John E. Kelly
Member
Bass, Berry & Sims

PANELISTS:

Kirk Ogrosky
Partner
Arnold & Porter Kaye Scholer LLP

Jed Dwyer
Shareholder
Greenberg Traurig, LLP

Ben Curtis
Senior Counsel
Broad & Cassel

12:00

What to Expect During a Monitor Review

Mark Scallon
Partner
Forensic Risk Alliance

Stacy Fresch
Partner
Forensic Risk Alliance

12:45

Networking Luncheon

1:45

Gain Strategies to Conduct Regional Risk Assessments to Prevent
FCPA Violations

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Gain Insight into Proactive Due Diligence, Monitoring and Auditing of Third-Parties and Distributors

2:30

THOUGHT LEADER PANEL Integrate Technology and Data Analytics to Improve Monitoring and Oversight Processes

MODERATOR:

Timothy Ayers
Vice President, Chief Compliance Officer
Horizon Pharma

PANELISTS:

Jim Jaakobs
Senior Audit Manager
Johnson & Johnson

Chian Boen
Sensitive Issue Manager, Corporate Internal Audit
Johnson & Johnson

Craig Clesson
Director, Compliance
Amgen

3:30

Networking and Refreshment Break

4:00

Prevent Bribery and Corruption through Robust Auditing Programs

Pierre Helfer
Executive Director Audit Services
Bristol-Myers Squibb

4:45

Manage Bribery and Corruption Risks in the Global Supply Chain

Charles Morton
Associate Director, Global Supply Chain Security
Merck

5:30

Close of Day One

NETWORKING, WINE AND CHEESE RECEPTION immediately following the final session on day one

DAY TWO WEDNESDAY, FEBRUARY 1, 2017

8:30

Continental Breakfast

9:00

Chairman’s Review of Day One

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Implement Strategies to Assess and Prepare for FCPA Risks in Emerging Markets

9:15

Examine Strategies for Conducting Due Diligence on Third-Parties and Distributors

Sumita Ray
Former Chief Compliance Officer
Pharmacyclics

10:00

Evaluate Operational Considerations and Risk Factors when Constructing a Global FMV Methodology

Craig Clesson
Director, Compliance
Amgen

10:45

Networking and Refreshment Break

11:15

SCENARIO PLANNING DISCUSSION

Shereen Ally, CPA, CFE
Lead Compliance and Forensics Specialist
Johnson & Johsnson

Niurka Johnson
Senior Manager, Compliance and Forensics
(Latin America, Middle East & Africa): Corporate Internal Audit
Johnson & Johnson

Gildas Durand
Principal, Assurance Services, French Business Network
Ernst & Young LLP

11:55

Fostering Effective HCP Interactions in an Era of Compliance

Hedilene Cardoso, MD
Medical Director
Eli Lilly do Brasil Ltda

12:15

Close of Conference

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, JANUARY 31, 2017

7:30

Conference Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Evaluate Legislative and Enforcement Trends Involving FCPA and Investigation Programs

8:45

LUMINARY ADDRESS Why Everyone in Your Organization Needs to Care about
Anti-Corruption (And Do They Really?)

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
Former FCPA Violator and FBI/UK Cooperator

Gary Giampetruzzi
Partner, Litigation Department
Paul Hastings

9:45

FCPA Enforcement Trends and Updates

MODERATOR:

John E. Kelly
Member
Bass, Berry & Sims

PANELISTS:

Glenn Pomerantz
Partner
BDO

Christian Perez Font
Chief Compliance Officer
OPKO Health

Maria Villanueva Sessions
Director of Compliance
Zimmer Biomet

10:45

Networking and Refreshment Break

11:15

FORMER PROSECUTOR VIEWPOINTS Life Sciences Enforcement Updates, Trends and Predictions

MODERATOR:

John E. Kelly
Member
Bass, Berry & Sims

PANELISTS:

Kirk Ogrosky
Partner
Arnold & Porter Kaye Scholer LLP

Jed Dwyer
Shareholder
Greenberg Traurig, LLP

Ben Curtis
Senior Counsel
Broad & Cassel

12:00

What to Expect During a Monitor Review

Mark Scallon
Partner
Forensic Risk Alliance

Stacy Fresch
Partner
Forensic Risk Alliance

12:45

Networking Luncheon

1:45

Gain Strategies to Conduct Regional Risk Assessments to Prevent
FCPA Violations

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Gain Insight into Proactive Due Diligence, Monitoring and Auditing of Third-Parties and Distributors

2:30

THOUGHT LEADER PANEL Integrate Technology and Data Analytics to Improve Monitoring and Oversight Processes

MODERATOR:

Timothy Ayers
Vice President, Chief Compliance Officer
Horizon Pharma

PANELISTS:

Jim Jaakobs
Senior Audit Manager
Johnson & Johnson

Chian Boen
Sensitive Issue Manager, Corporate Internal Audit
Johnson & Johnson

Craig Clesson
Director, Compliance
Amgen

3:30

Networking and Refreshment Break

4:00

Prevent Bribery and Corruption through Robust Auditing Programs

Pierre Helfer
Executive Director Audit Services
Bristol-Myers Squibb

4:45

Manage Bribery and Corruption Risks in the Global Supply Chain

Charles Morton
Associate Director, Global Supply Chain Security
Merck

5:30

Close of Day One

NETWORKING, WINE AND CHEESE RECEPTION immediately following the final session on day one

DAY TWO WEDNESDAY, FEBRUARY 1, 2017

8:30

Continental Breakfast

9:00

Chairman’s Review of Day One

Jeffrey Antoon
Internal Audit Director
Johnson & Johnson

Implement Strategies to Assess and Prepare for FCPA Risks in Emerging Markets

9:15

Examine Strategies for Conducting Due Diligence on Third-Parties and Distributors

Sumita Ray
Former Chief Compliance Officer
Pharmacyclics

10:00

Evaluate Operational Considerations and Risk Factors when Constructing a Global FMV Methodology

Craig Clesson
Director, Compliance
Amgen

10:45

Networking and Refreshment Break

11:15

SCENARIO PLANNING DISCUSSION

Shereen Ally, CPA, CFE
Lead Compliance and Forensics Specialist
Johnson & Johsnson

Niurka Johnson
Senior Manager, Compliance and Forensics
(Latin America, Middle East & Africa): Corporate Internal Audit
Johnson & Johnson

Gildas Durand
Principal, Assurance Services, French Business Network
Ernst & Young LLP

11:55

Fostering Effective HCP Interactions in an Era of Compliance

Hedilene Cardoso, MD
Medical Director
Eli Lilly do Brasil Ltda

12:15

Close of Conference